Canada markets closed

Apyx Medical Corporation (APYX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.1800-0.0200 (-1.67%)
At close: 04:00PM EDT
1.1700 -0.01 (-0.85%)
After hours: 04:06PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 40.88M
Enterprise Value 46.90M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.83
Price/Book (mrq)2.77
Enterprise Value/Revenue 0.96
Enterprise Value/EBITDA -5.33

Trading Information

Stock Price History

Beta (5Y Monthly) 1.20
52-Week Change 3-53.17%
S&P500 52-Week Change 332.96%
52 Week High 33.2600
52 Week Low 30.9670
50-Day Moving Average 31.2111
200-Day Moving Average 31.6108

Share Statistics

Avg Vol (3 month) 336.48k
Avg Vol (10 day) 324.51k
Shares Outstanding 534.64M
Implied Shares Outstanding 634.64M
Float 825.92M
% Held by Insiders 116.18%
% Held by Institutions 140.45%
Shares Short (Sept 30, 2024) 4236.05k
Short Ratio (Sept 30, 2024) 46.32
Short % of Float (Sept 30, 2024) 40.73%
Short % of Shares Outstanding (Sept 30, 2024) 40.68%
Shares Short (prior month Aug 30, 2024) 4265.06k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin -57.86%
Operating Margin (ttm)-45.66%

Management Effectiveness

Return on Assets (ttm)-21.83%
Return on Equity (ttm)-110.25%

Income Statement

Revenue (ttm)49.03M
Revenue Per Share (ttm)1.41
Quarterly Revenue Growth (yoy)-10.50%
Gross Profit (ttm)N/A
EBITDA -21.67M
Net Income Avi to Common (ttm)-28.37M
Diluted EPS (ttm)-0.8200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)32.68M
Total Cash Per Share (mrq)0.94
Total Debt (mrq)38.7M
Total Debt/Equity (mrq)259.32%
Current Ratio (mrq)5.33
Book Value Per Share (mrq)0.43

Cash Flow Statement

Operating Cash Flow (ttm)-9.19M
Levered Free Cash Flow (ttm)3.78M